These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3128179)

  • 1. Mechanism of reductive activation of a 5-nitroimidazole by flavoproteins: model studies with dithionite.
    Kedderis GL; Argenbright LS; Miwa GT
    Arch Biochem Biophys; 1988 Apr; 262(1):40-8. PubMed ID: 3128179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent interaction of 5-nitroimidazoles with DNA and protein in vitro: mechanism of reductive activation.
    Kedderis GL; Argenbright LS; Miwa GT
    Chem Res Toxicol; 1989; 2(3):146-9. PubMed ID: 2519718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteine.
    Wislocki PG; Bagan ES; Vandenheuvel WJ; Walker RW; Alvaro RF; Arison BH; Lu AY; Wolf FJ
    Chem Biol Interact; 1984 Apr; 49(1-2):13-25. PubMed ID: 6722933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug residue formation from ronidazole, a 5-nitroimidazole. III. Studies on the mechanism of protein alkylation in vitro.
    Miwa GT; West SB; Walsh JS; Wolf FJ; Lu AY
    Chem Biol Interact; 1982 Sep; 41(3):297-312. PubMed ID: 6809347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitro.
    West SB; Wislocki PG; Wolf FJ; Lu AY
    Chem Biol Interact; 1982 Sep; 41(3):281-96. PubMed ID: 6809346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation.
    West SB; Wislocki PG; Fiorentini KM; Alvaro R; Wolf FJ; Lu AY
    Chem Biol Interact; 1982 Sep; 41(3):265-79. PubMed ID: 6809345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the reaction kinetics of cytochrome P-450 reduction by NADPH-cytochrome P-450 reductase and dithionite].
    Davydov DR; Kurganov BI
    Biokhimiia; 1982 Sep; 47(9):1476-82. PubMed ID: 6814537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroimidazole bioreductive metabolism. Quantitation and characterisation of mouse tissue benznidazole nitroreductases in vivo and in vitro.
    Walton MI; Workman P
    Biochem Pharmacol; 1987 Mar; 36(6):887-96. PubMed ID: 3105539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug residue formation from ronidazole, a 5-nitroimidazole. VI. Lack of mutagenic activity of reduced metabolites and derivatives of ronidazole.
    Wislocki PG; Bagan ES; Cook MM; Bradley MO; Wolf FJ; Lu AY
    Chem Biol Interact; 1984 Apr; 49(1-2):27-38. PubMed ID: 6722938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of activation and the mutagenicity of ronidazole, a 5-nitroimidazole.
    Miwa GT; Wislocki P; Bagan E; Wang R; Walsh JS; Lu AY
    Adv Exp Med Biol; 1986; 197():527-35. PubMed ID: 3766278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase.
    Pan SS; Andrews PA; Glover CJ; Bachur NR
    J Biol Chem; 1984 Jan; 259(2):959-66. PubMed ID: 6319393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The degradation of haem by carbon tetrachloride: metabolic activation requires a free axial coordination site on the haem iron and electron donation.
    Manno M; King LJ; De Matteis F
    Xenobiotica; 1989 Sep; 19(9):1023-35. PubMed ID: 2510407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug residue formation from ronidazole, a 5-nitroimidazole. VII. Comparison of protein-bound products formed in vitro and in vivo.
    Miwa GT; Alvaro RF; Walsh JS; Wang R; Lu AY
    Chem Biol Interact; 1984 Jul; 50(2):189-202. PubMed ID: 6744464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic activation of ronidazole [(1-methyl-5-nitroimidazole-2-yl)-methyl carbamate] to reactive metabolites by mammalian, cecal bacterial and T. foetus enzymes.
    Miwa GT; Wang R; Alvaro R; Walsh JS; Lu AY
    Biochem Pharmacol; 1986 Jan; 35(1):33-6. PubMed ID: 3940524
    [No Abstract]   [Full Text] [Related]  

  • 15. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
    Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
    J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase.
    Clarke ED; Goulding KH; Wardman P
    Biochem Pharmacol; 1982 Oct; 31(20):3237-42. PubMed ID: 6897358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug residue formation from ronidazole, a 5-nitro-imidazole. IV. The role of the microflora.
    Wolf FJ; Alvaro RF; Fiorentini K; Green M; Lu AY; Miwa GT; Wislocki PG; Koch RT; McLafferty MA; Goldman P
    Chem Biol Interact; 1983 Jul; 45(1):7-14. PubMed ID: 6872101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of a reducible disulfide bond in milk xanthine oxidase.
    Hille R; Massey V
    J Biol Chem; 1982 Aug; 257(15):8898-901. PubMed ID: 6284747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of misonidazole by rat liver microsomes and purified NADPH-cytochrome c reductase.
    McManus ME; Lang MA; Stuart K; Strong J
    Biochem Pharmacol; 1982 Feb; 31(4):547-52. PubMed ID: 6802140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.